Company Filing History:
Years Active: 2017
Title: Innovation in GPCR Structural Biology by Inventor Sebastian Granier
Introduction:
Sebastian Granier is a visionary inventor based in Menlo Park, CA, with a penchant for groundbreaking scientific discoveries in the field of G protein coupled receptor (GPCR) structural biology. With a keen focus on unraveling the complexities of GPCR:G protein complexes, Granier's work has paved the way for advanced understanding and novel applications in this crucial area of research.
Latest Patents:
Granier's notable patent, titled "Binding domains directed against GPCR:G protein complexes and uses derived thereof," stands as a testament to his innovative contributions. This patent introduces binding domains that specifically target GPCR:G protein interactions, offering a universal tool for exploring the structural and functional aspects of these receptor complexes.
Career Highlights:
Throughout his career, Granier has been associated with esteemed institutions such as Vrije Universiteit Brussel and Vib Vzw, where he has spearheaded pioneering research initiatives. His singular focus on GPCR biology has garnered international recognition and positioned him as a trailblazer in the field of structural biology.
Collaborations:
Collaborating with esteemed peers like Jan Steyaert and Els Pardon, Granier has fostered a dynamic research environment conducive to innovation and knowledge exchange. Together, they have pushed the boundaries of GPCR research, leading to groundbreaking discoveries and novel applications in drug discovery and screening efforts.
Conclusion:
In conclusion, Sebastian Granier's inventive spirit and dedication to GPCR structural biology exemplify the essence of innovation in scientific research. His patent on binding domains targeting GPCR:G protein complexes underscores his commitment to pushing the boundaries of knowledge and unlocking new possibilities in the realm of biotechnology. Granier's collaborative efforts and career milestones reflect a legacy of excellence and a drive to revolutionize the field of structural biology.